You're invited to join the esteemed Fierce Pharma editorial team at the Drug Development and Delivery Insights for 2024. This complimentary half-day virtual event, scheduled for May 30, 2024, from 1:00pm - 4:30pm EDT, is your gateway to the latest trends and insights for the industry.

REGISTER NOW

Exclusive Sessions Tailored Just For you:

Charting the Course for Oral Biologics Delivery
Explore the complexities surrounding the oral delivery of biologics and look ahead to potential developments in the coming years.

Kevin Dunleavy
Staff Writer, Fierce Pharma
Moderator

Ngoc Thai, MD, PhD
Founder, Co-CEO and Chief Medical Officer, Imagine Pharma

Stephen Buckley
Scientific Vice President of Advance Drug Delivery, Novo Nordisk

Advances and Challenges in Developing Ultra-Long-Acting Drug Delivery Platforms
Explore the strategic timing for pharmaceutical companies to pursue long-acting versions of their drug candidates and examine key considerations in delivery platform development.

Fraiser Kansteiner
Staff Writer, Fierce Pharma
Moderator

Eran Harary, MD
SVP, Clinical Development, Innovative Medicines R&D, Teva

Daria Hazuda, Ph.D.
Head of Infectious Disease and Vaccines Research, Generate:Biomedicines

Richard Scranton, MD, MPH
President of Global Product Development and Chief Medical Officer, Lyndra Therapeutics

Sherene Min, MD, MPH
VP, Head of Global Clinical Development, ViiV Healthcare

VIEW FULL AGENDA

Thank you to Our 2024 Sponsors

Fierce Pharma Forward: Drug Development and Delivery Insights for 2024

If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.

Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017